J
Junhua Zhao
Researcher at China Medical University (PRC)
Publications - 42
Citations - 1686
Junhua Zhao is an academic researcher from China Medical University (PRC). The author has contributed to research in topics: Cancer & Hazard ratio. The author has an hindex of 20, co-authored 40 publications receiving 1255 citations. Previous affiliations of Junhua Zhao include Chinese Ministry of Education.
Papers
More filters
Journal ArticleDOI
Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion
Yongxi Song,Jingxu Sun,Junhua Zhao,Yuchong Yang,Jinxin Shi,Zhonghua Wu,Xiaowan Chen,Peng Gao,Zhi-feng Miao,Zhi-feng Miao,Zhenning Wang +10 more
TL;DR: A regulatory network in gastric cancer is revealed whereby claudin-4 expression is reduced by specific miRNAs, which are in turn bound by specific lncRNAs acting as competing endogenous RNAs (ceRNAs), resulting in increased claudIn-4expression.
Journal ArticleDOI
The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis
TL;DR: PNI was a predictive indicator of survival and postoperative complications, and was associated with clinicopathological features in GC patients, however, a low PNI was not significantly associated with poor OS in patients with GC at stage IV.
Journal ArticleDOI
Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer
Xuanzhang Huang,Peng Gao,Yongxi Song,Jingxu Sun,Xiaowan Chen,Junhua Zhao,Huimian Xu,Zhenning Wang +7 more
TL;DR: A meta-analysis indicates that the detection of CTCs in the peripheral blood with the CellSearch System has prognostic utility for patients with CRC.
Journal ArticleDOI
Antibiotic use and the efficacy of immune checkpoint inhibitors in cancer patients: a pooled analysis of 2740 cancer patients.
Xuanzhang Huang,Peng Gao,Yongxi Song,Yan Xu,Jingxu Sun,Xiaowan Chen,Junhua Zhao,Zhenning Wang +7 more
TL;DR: A first meta-analysis to evaluate the association between ATB use and ICI efficacy in cancer patients to provide a better understanding of the strength of this association indicated that ATBUse is negatively associated with OS and PFS in cancer Patients treated with ICI immunotherapy.
Journal ArticleDOI
What has preoperative radio(chemo)therapy brought to localized rectal cancer patients in terms of perioperative and long-term outcomes over the past decades? A systematic review and meta-analysis based on 41,121 patients.
Bin Ma,Peng Gao,Hongchi Wang,Qingzhou Xu,Yongxi Song,Xuanzhang Huang,Xuanzhang Huang,Jingxu Sun,Junhua Zhao,Junlong Luo,Yu Sun,Zhenning Wang +11 more
TL;DR: The greatest advantage of PRT/PCRT is still local tumor control and a significantly improved LRFS, but neither overall survival (OS) nor metastasis‐free survival (MFS) showed improvement.